Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study

Our objective was to assess the safety and efficacy of olaparib in maintenance therapy of BRCA 1-2 mutated, platinum-sensitive, recurrent ovarian carcinoma after the partial or complete response to the second or further lines platinum-based chemotherapy in a real-world setting. We performed a multic...

Descripción completa

Detalles Bibliográficos
Autores principales: Majić, Ana, Miše, Branka Petrić, Matković, Višnja, Belac Lovasić, Ingrid, Katić, Kristina, Canjko, Ivana, Frobe, Ana, Bajić, Žarko, Vrdoljak, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322596/
https://www.ncbi.nlm.nih.gov/pubmed/32655639
http://dx.doi.org/10.1155/2020/6423936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322596/
https://www.ncbi.nlm.nih.gov/pubmed/32655639
http://dx.doi.org/10.1155/2020/6423936

Ejemplares similares